Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Amgen unveils double whammy of data for its investigational cancer immunotherapies at ASH 2018

pharmafileDecember 07, 2018

Tag: ASH , AML , Amgen

PharmaSources Customer Service